Effects of Co‐administration of Sulfonylureas and Antimicrobial Drugs on Hypoglycemia in Patients with Type 2 Diabetes Using a Case‐Crossover Design-Reference-Cited by-同舟云学术

Effects of Co‐administration of Sulfonylureas and Antimicrobial Drugs on Hypoglycemia in Patients with Type 2 Diabetes Using a Case‐Crossover Design

Published:2020-08-13 Issue: Volume: Page:
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Lee Sera¹,Ock Miyoung¹,Kim Hun‐Sung²³^ORCID,Kim Hyunah¹⁴^ORCID

Affiliation:

1. College of Pharmacy Sookmyung Women’s University Seoul Korea

2. Department of Medical Informatics College of Medicine The Catholic University of Korea Seoul Korea

3. Division of Endocrinology and Metabolism Department of Internal Medicine College of Medicine Seoul St. Mary’s Hospital The Catholic University of Korea Seoul Korea

4. Drug Information Research Institute Sookmyung Women’s University Seoul Korea

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2450

Reference46 articles.

1. Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study

2. Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study

3. Diabetes and Infection: Is There a Link? - A Mini-Review

4. Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population‐based cohort study;Diabetes, Obesity and Metabolism;2024-05-02

2. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11

3. Evaluating the use of methods to mitigate bias from non‐transient medications in the case‐crossover design: A systematic review;Pharmacoepidemiology and Drug Safety;2023-06-15

4. Safety and Tolerability of Antimicrobial Agents in the Older Patient;Drugs & Aging;2023-03-28